Skip to main content

Balyasny Asset Management L.P.

Position in TXG — 10x Genomics, Inc.

CIK 1218710 Chicago, IL

Position in TXG

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$21,007,552
+$18,996,075 QoQ
Shares Held
989,522
+606.4% QoQ
Ownership
0.779%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TXG Over Time

Shares Held

Position Value (USD)

Derivatives in TXG

reported options exposure · as of Mar 31, 2023
CallValue
$3,626,350
CallShares
65,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Health Information Services

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $166,051,865 across 14 Health Information Services names. TXG ranks #3 (12.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 TXG
10x Genomics, Inc.
This page
989,522 $21,007,552

All Filings in TXG

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,007,552 989,522
2024-12-31 $2,011,477 140,075
2024-09-30 $999,277 44,255
2024-06-30 $1,562,048 80,311
2023-12-31 $1,216,850 21,745
2023-03-31 $37,762,074 676,861
2023-03-31 $3,626,350 65,000
2022-06-30 $1,364,106 30,146
2021-03-31 $3,574,931 19,751
2020-12-31 $8,363,320 59,063
2020-06-30 $1,147,454 12,848